Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Uscom Limited ( (AU:UCM) ) has issued an update.
Uscom Limited announced a change in the director’s interest, with Robert Allan Phillips converting 9,670,117 performance rights into ordinary shares, increasing his total holdings to 93,958,881 shares. This conversion, approved at the 2024 AGM, reflects a strategic move to align the director’s interests with the company’s growth, potentially impacting stakeholder confidence and market perception positively.
More about Uscom Limited
Uscom Limited operates in the medical technology industry, focusing on the development and distribution of non-invasive cardiovascular and pulmonary medical devices. The company aims to provide innovative solutions for the diagnosis and management of heart and lung diseases, targeting healthcare providers and patients globally.
Average Trading Volume: 280,019
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$4.01M
Find detailed analytics on UCM stock on TipRanks’ Stock Analysis page.